Riskpilot← Back to searchSign inGet full accessDjurläkarn i Orsa AB
ABActiveOrg 5567706394Järnvägsgatan 21Veterinary activities · NACE 7500Est. 20081-4 employees
Revenue 2025
SEK 4,2M
-22% vs 2024
EBITDA margin
13.0%
+152% vs 2024
Equity ratio
33.3%
Financial strength
Net profit 2025
SEK 240K
+275% vs 2024
| Revenue | SEK 4,2M | -22% |
| EBITDA | SEK 548K | +152% |
| Net profit | SEK 240K | +275% |
| Total assets | SEK 1,7M | -5% |
| Equity | SEK 563K | +33% |
| Employees | — | — |
Legal name
Djurläkarn i Orsa AB
Org number
5567706394
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
21 november 2008
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva veterinärklinik och därmed förenlig verksamhet.
Address
Järnvägsgatan 21
Phone
+4625043408
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 823 | 3 589 | 6 427 | 5 427 | 4 211 |
| Staff expenses | — | — | — | — | −1 914 |
| EBITDA | 231 | 274 | 617 | 217 | 548 |
| Depreciation & amort. | −189 | −139 | −299 | −174 | −159 |
| EBIT | 42 | 135 | 318 | 43 | 389 |
| Net financials | −19 | −19 | −40 | −28 | −18 |
| Profit before tax | 23 | 52 | 17 | 84 | 306 |
| Tax | −8 | −10 | −10 | −20 | −67 |
| Net profit | 15 | 42 | 7 | 64 | 240 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 332 | 1 373 | 2 323 | 1 785 | 1 691 |
| Equity | 410 | 452 | 359 | 423 | 563 |
| Long-term debt | 205 | 135 | 528 | 308 | 154 |
| Short-term debt | 495 | 501 | 946 | 634 | 490 |
| Total debt | 700 | 636 | 1 474 | 942 | — |
EBITDA margin
13.0%
This company
15.8%
Market median
-18% vs market
20212025
Equity ratio
33.3%
This company
38.2%
Market median
+13% vs market
20212025
Return on equity
42.6%
This company
18.4%
Market median
+132% vs market
20212025
Net profit margin
5.7%
This company
8.1%
Market median
-30% vs market
20212025
Asset turnover
2.49×
This company
1.12×
Market median
+122% vs market
20212025
Debt / equity
2.00×
This company
0.62×
Market median
-223% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JP Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Djurläkarn i Orsa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Patrik Gilljam | Audit | 0 companies |
| Johannes Hütter | Deputy Board Member | 0 companies |
| Thomas Hütter | Board of Directors | 0 companies |